Skip to main content
Top
Gepubliceerd in:

08-12-2017

Evaluating cognition in individuals with Huntington disease: Neuro-QoL cognitive functioning measures

Auteurs: Jin-Shei Lai, Siera Goodnight, Nancy R. Downing, Rebecca E. Ready, Jane S. Paulsen, Anna L. Kratz, Julie C. Stout, Michael K. McCormack, David Cella, Christopher Ross, Jenna Russell, Noelle E. Carlozzi

Gepubliceerd in: Quality of Life Research | Uitgave 3/2018

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

Cognitive functioning impacts health-related quality of life (HRQOL) for individuals with Huntington disease (HD). The Neuro-QoL includes two patient-reported outcome (PRO) measures of cognition—Executive Function (EF) and General Concerns (GC). These measures have not previously been validated for use in HD. The purpose of this analysis is to evaluate the reliability and validity of the Neuro-QoL Cognitive Function measures for use in HD.

Methods

Five hundred ten individuals with prodromal or manifest HD completed the Neuro-QoL Cognition measures, two other PRO measures of HRQOL (WHODAS 2.0 and EQ5D), and a depression measure (PROMIS Depression). Measures of functioning The Total Functional Capacity and behavior (Problem Behaviors Assessment) were completed by clinician interview. Objective measures of cognition were obtained using clinician-administered Symbol Digit Modalities Test and the Stroop Test (Word, Color, and Interference). Self-rated, clinician-rated, and objective composite scores were developed. We examined the Neuro-QoL measures for reliability, convergent validity, discriminant validity, and known-groups validity.

Results

Excellent reliabilities (Cronbach’s alphas ≥ 0.94) were found. Convergent validity was supported, with strong relationships between self-reported measures of cognition. Discriminant validity was supported by less robust correlations between self-reported cognition and other constructs. Prodromal participants reported fewer cognitive problems than manifest groups, and early-stage HD participants reported fewer problems than late-stage HD participants.

Conclusions

The Neuro-QoL Cognition measures provide reliable and valid assessments of self-reported cognitive functioning for individuals with HD. Findings support the utility of these measures for assessing self-reported cognition.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference MacDonald, M. E., Ambrose, C. M., Duyao, M. P., Myers, R. H., Lin, C., Srinidhi, L., Barnes, G., Taylor, S. A., James, M., & Groot, N. & Huntington’s Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell, 72(6), 971–983.CrossRef MacDonald, M. E., Ambrose, C. M., Duyao, M. P., Myers, R. H., Lin, C., Srinidhi, L., Barnes, G., Taylor, S. A., James, M., & Groot, N. & Huntington’s Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell, 72(6), 971–983.CrossRef
2.
go back to reference Squitieri, F., Griguoli, A., Capelli, G., Porcellini, A., & D’Alessio, B. (2016). Epidemiology of Huntington disease: First post-HTT gene analysis of prevalence in Italy. Clinical Genetics, 89(3), 367–370.CrossRefPubMed Squitieri, F., Griguoli, A., Capelli, G., Porcellini, A., & D’Alessio, B. (2016). Epidemiology of Huntington disease: First post-HTT gene analysis of prevalence in Italy. Clinical Genetics, 89(3), 367–370.CrossRefPubMed
3.
go back to reference Ross, C. A., Aylward, E. H., Wild, E. J., Langbehn, D. R., Long, J. D., Warner, J. H., Scahill, R. I., Leavitt, B. R., Stout, J. C., & Paulsen, J. S. (2014). Huntington disease: Natural history, biomarkers and prospects for therapeutics. Nature Reviews Neurology, 10, 204–216.CrossRefPubMed Ross, C. A., Aylward, E. H., Wild, E. J., Langbehn, D. R., Long, J. D., Warner, J. H., Scahill, R. I., Leavitt, B. R., Stout, J. C., & Paulsen, J. S. (2014). Huntington disease: Natural history, biomarkers and prospects for therapeutics. Nature Reviews Neurology, 10, 204–216.CrossRefPubMed
4.
go back to reference Evans, S. J. W., Douglas, I., Rawlins, M. D., Wexler, N. S., Tabrizi, S. J., & Smeeth, L. (2013). Prevalence of adult Huntington’s disease in the UK based on diagnoses recorded in general practice records. Journal of Neurology, Neurosurgery & Psychiatry, 84(10), 1156–1160.CrossRef Evans, S. J. W., Douglas, I., Rawlins, M. D., Wexler, N. S., Tabrizi, S. J., & Smeeth, L. (2013). Prevalence of adult Huntington’s disease in the UK based on diagnoses recorded in general practice records. Journal of Neurology, Neurosurgery & Psychiatry, 84(10), 1156–1160.CrossRef
5.
go back to reference Rawlins, M. D., Wexler, N. S., Wexler, A. R., Tabrizi, S. J., Douglas, I., Evans, S. J., & Smeeth, L. (2016). The prevalence of huntington’s disease. Neuroepidemiology, 46(2), 144–153.CrossRefPubMed Rawlins, M. D., Wexler, N. S., Wexler, A. R., Tabrizi, S. J., Douglas, I., Evans, S. J., & Smeeth, L. (2016). The prevalence of huntington’s disease. Neuroepidemiology, 46(2), 144–153.CrossRefPubMed
6.
go back to reference Paulsen, J. S. (2010). Early detection of Huntington’s disease. Future Neurology, 5(1), 85–104.CrossRef Paulsen, J. S. (2010). Early detection of Huntington’s disease. Future Neurology, 5(1), 85–104.CrossRef
7.
go back to reference Carlozzi, N. E., & Tulsky, D. S. (2013). Identification of health-related quality of life (HRQOL) issues relevant to individuals with Huntington disease. Journal of Health Psychology, 18(2), 212–225.CrossRefPubMed Carlozzi, N. E., & Tulsky, D. S. (2013). Identification of health-related quality of life (HRQOL) issues relevant to individuals with Huntington disease. Journal of Health Psychology, 18(2), 212–225.CrossRefPubMed
8.
go back to reference U.S. Department of Health and Human Services. (2000). Healthy people 2010: Understanding and improving health (2nd ed.). Washington, DC: U.S. Government Printing Office. U.S. Department of Health and Human Services. (2000). Healthy people 2010: Understanding and improving health (2nd ed.). Washington, DC: U.S. Government Printing Office.
9.
go back to reference Mickes, L., Jacobson, M., Peavy, G., Wixted, J. T., Lessig, S., Goldstein, J. L., & Corey-Bloom, J. (2010). A comparison of two brief screening measures of cognitive impairment in Huntington’s disease. Movement Disorders, 25(13), 2229–2233.CrossRefPubMed Mickes, L., Jacobson, M., Peavy, G., Wixted, J. T., Lessig, S., Goldstein, J. L., & Corey-Bloom, J. (2010). A comparison of two brief screening measures of cognitive impairment in Huntington’s disease. Movement Disorders, 25(13), 2229–2233.CrossRefPubMed
10.
go back to reference Stout, J. C., Glikmann-Johnston, Y., & Andrews, S. C. (2016). Cognitive assessment strategies in Huntington’s disease research. Journal of Neuroscience Methods, 265, 19–24.CrossRefPubMed Stout, J. C., Glikmann-Johnston, Y., & Andrews, S. C. (2016). Cognitive assessment strategies in Huntington’s disease research. Journal of Neuroscience Methods, 265, 19–24.CrossRefPubMed
11.
go back to reference Kremer, H. P. H. & Hungtington Study Group. (1996). Unified Huntington’s disease rating scale: Reliability and consistency. Movement Disorders, 11, 136–142.CrossRef Kremer, H. P. H. & Hungtington Study Group. (1996). Unified Huntington’s disease rating scale: Reliability and consistency. Movement Disorders, 11, 136–142.CrossRef
12.
go back to reference Stout, J. C., Paulsen, J. S., Queller, S., Solomon, A. C., Whitlock, K. B., Campbell, J. C., Carlozzi, N., Duff, K., Beglinger, L. J., Langbehn, D. R., Johnson, S. A., Biglan, K. M., & Aylward, E. H. (2011). Neurocognitive signs in prodromal Huntington disease. Neuropsychology, 25(1), 1–14.CrossRefPubMedPubMedCentral Stout, J. C., Paulsen, J. S., Queller, S., Solomon, A. C., Whitlock, K. B., Campbell, J. C., Carlozzi, N., Duff, K., Beglinger, L. J., Langbehn, D. R., Johnson, S. A., Biglan, K. M., & Aylward, E. H. (2011). Neurocognitive signs in prodromal Huntington disease. Neuropsychology, 25(1), 1–14.CrossRefPubMedPubMedCentral
13.
go back to reference Smith, A. (1995). Symbol digit modalities test: Manual. Los Angeles: Western Psychological Services. Smith, A. (1995). Symbol digit modalities test: Manual. Los Angeles: Western Psychological Services.
14.
go back to reference Stroop, J. R. (1992). Studies of interference in serial verbal reactions (Reprinted from Journal Experimental-Psychology, vol. 18, pp. 643–662, 1935). Journal of Experimental Psychology-General, 121(1), 15–23.CrossRef Stroop, J. R. (1992). Studies of interference in serial verbal reactions (Reprinted from Journal Experimental-Psychology, vol. 18, pp. 643–662, 1935). Journal of Experimental Psychology-General, 121(1), 15–23.CrossRef
15.
go back to reference Stroop, J. R. (1935). Studies of interference in serial verbal reactions. Journal of Experimental Psychology, 18, 643–662.CrossRef Stroop, J. R. (1935). Studies of interference in serial verbal reactions. Journal of Experimental Psychology, 18, 643–662.CrossRef
16.
go back to reference Benton, A. L., Sivan, A. B., Hamsher, K. D., Varney, N. R., & Spreen, O. (1994). Contributions to neuropsychological assessment (2nd ed.). New York: Oxford University Press. Benton, A. L., Sivan, A. B., Hamsher, K. D., Varney, N. R., & Spreen, O. (1994). Contributions to neuropsychological assessment (2nd ed.). New York: Oxford University Press.
17.
go back to reference Conway, M. A. (1991). In defense of everyday memory. American Psychologist, 46(1), 19–26.CrossRef Conway, M. A. (1991). In defense of everyday memory. American Psychologist, 46(1), 19–26.CrossRef
18.
go back to reference Loftus, E. F. (1991). The glitter of everyday memory … and the gold. American Psychologist, 46(1), 16–18.CrossRefPubMed Loftus, E. F. (1991). The glitter of everyday memory … and the gold. American Psychologist, 46(1), 16–18.CrossRefPubMed
19.
go back to reference Chaytor, N., & Schmitter-Edgecombe, M. (2003). The ecological validity of neuropsychological tests: A review of the literature on everyday cognitive skills. Neuropsychology Review, 13(4), 181–197.CrossRefPubMed Chaytor, N., & Schmitter-Edgecombe, M. (2003). The ecological validity of neuropsychological tests: A review of the literature on everyday cognitive skills. Neuropsychology Review, 13(4), 181–197.CrossRefPubMed
20.
go back to reference Silver, C. H. (2000). Ecological validity of neuropsychological assessment in childhood traumatic brain injury. The Journal of Head Trauma Rehabilitation, 15(4), 973–988.CrossRefPubMed Silver, C. H. (2000). Ecological validity of neuropsychological assessment in childhood traumatic brain injury. The Journal of Head Trauma Rehabilitation, 15(4), 973–988.CrossRefPubMed
21.
go back to reference Hutchinson, A. D., Hosking, J. R., Kichenadasse, G., Mattiske, J. K., & Wilson, C. (2012). Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review. Cancer Treatment Reviews, 38(7), 926–934.CrossRefPubMed Hutchinson, A. D., Hosking, J. R., Kichenadasse, G., Mattiske, J. K., & Wilson, C. (2012). Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review. Cancer Treatment Reviews, 38(7), 926–934.CrossRefPubMed
22.
go back to reference Cella, D., Lai, J. S., Nowinski, C., Victorson, D., Peterman, A., Miller, D., Bethoux, F., Heinemann, A., Rubin, S., Cavasos, J., Reder, A., Sufit, R., Simuni, T., Holmes, G., Siderowf, A., Wojna, V., Bode, R., McKinney, N., Podrabsky, T., Wortman, K., Choi, S., Gershon, R., Rothrock, N., & Moy, C. (2012). Neuro-QOL: Brief measures of health-related quality of life for clinical research in neurology. Neurology, 78, 1860–1867.CrossRefPubMedPubMedCentral Cella, D., Lai, J. S., Nowinski, C., Victorson, D., Peterman, A., Miller, D., Bethoux, F., Heinemann, A., Rubin, S., Cavasos, J., Reder, A., Sufit, R., Simuni, T., Holmes, G., Siderowf, A., Wojna, V., Bode, R., McKinney, N., Podrabsky, T., Wortman, K., Choi, S., Gershon, R., Rothrock, N., & Moy, C. (2012). Neuro-QOL: Brief measures of health-related quality of life for clinical research in neurology. Neurology, 78, 1860–1867.CrossRefPubMedPubMedCentral
23.
go back to reference Cella, D., Nowinski, C., Peterman, A., Victorson, D., Miller, D., Lai, J.-S., & Moy, C. (2011). The neurology quality of life measurement (Neuro-QOL) initiative. Archives of Physical Medicine and Rehabilitation, 92(Suppl 1), S28-S36.PubMedCentral Cella, D., Nowinski, C., Peterman, A., Victorson, D., Miller, D., Lai, J.-S., & Moy, C. (2011). The neurology quality of life measurement (Neuro-QOL) initiative. Archives of Physical Medicine and Rehabilitation, 92(Suppl 1), S28-S36.PubMedCentral
24.
go back to reference Hambleton, R. K., Swaminathan, H., & Rogers, H. J. (1991). Fundamentals of item response theory. Newbury Park, CA: SAGE Publications, Inc. Hambleton, R. K., Swaminathan, H., & Rogers, H. J. (1991). Fundamentals of item response theory. Newbury Park, CA: SAGE Publications, Inc.
25.
go back to reference Wright, B. D., & Masters, G. N. (1985). Rating scale analysis: Rasch measurement. Chicago: MESA Press. Wright, B. D., & Masters, G. N. (1985). Rating scale analysis: Rasch measurement. Chicago: MESA Press.
26.
go back to reference Perez, L., Huang, J., Jansky, L., Nowinski, C., Victorson, D., Peterman, A., & Cella, D. (2007). Using focus groups to inform the Neuro-QOL measurement tool: exploring patient-centered, health-related quality of life concepts across neurological conditions. Journal of Neuroscience Nursing, 39(6), 342–353.CrossRefPubMed Perez, L., Huang, J., Jansky, L., Nowinski, C., Victorson, D., Peterman, A., & Cella, D. (2007). Using focus groups to inform the Neuro-QOL measurement tool: exploring patient-centered, health-related quality of life concepts across neurological conditions. Journal of Neuroscience Nursing, 39(6), 342–353.CrossRefPubMed
27.
go back to reference Gershon, R., Lai, J., Bode, R., Choi, S., Moy, C., Bleck, T., Miller, D., Peterman, A., & Cella, D. (2012). Neuro-QOL: Quality of life item banks for adults with neurological disorders: Item development and calibrations based upon clinical and general population testing. Quality of Life Research, 21(3), 475–486.CrossRefPubMed Gershon, R., Lai, J., Bode, R., Choi, S., Moy, C., Bleck, T., Miller, D., Peterman, A., & Cella, D. (2012). Neuro-QOL: Quality of life item banks for adults with neurological disorders: Item development and calibrations based upon clinical and general population testing. Quality of Life Research, 21(3), 475–486.CrossRefPubMed
28.
go back to reference Rock, P., Roiser, J., Riedel, W., & Blackwell, A. (2014). Cognitive impairment in depression: A systematic review and meta-analysis. Psychological Medicine, 44(10), 2029.CrossRefPubMed Rock, P., Roiser, J., Riedel, W., & Blackwell, A. (2014). Cognitive impairment in depression: A systematic review and meta-analysis. Psychological Medicine, 44(10), 2029.CrossRefPubMed
29.
go back to reference Carlozzi, N. E., Schilling, S. G., Lai, J. S., Paulsen, J. S., Hahn, E. A., Perlmutter, J. S., Ross, C. A., Downing, N. R., Kratz, A. L., McCormack, M. K., Nance, M. A., Quaid, K. A., Stout, J. C., Gershon, R. C., Ready, R. E., Miner, J. A., Barton, S. K., Perlman, S. L., Rao, S. M., Frank, S., Shoulson, I., Marin, H., Geschwind, M. D., Dayalu, P., Goodnight, S. M., & Cella, D. (2016). HDQLIFE: Development and assessment of health-related quality of life in Huntington disease (HD). Quality of Life Research, 25(10), 2441–2455.CrossRefPubMed Carlozzi, N. E., Schilling, S. G., Lai, J. S., Paulsen, J. S., Hahn, E. A., Perlmutter, J. S., Ross, C. A., Downing, N. R., Kratz, A. L., McCormack, M. K., Nance, M. A., Quaid, K. A., Stout, J. C., Gershon, R. C., Ready, R. E., Miner, J. A., Barton, S. K., Perlman, S. L., Rao, S. M., Frank, S., Shoulson, I., Marin, H., Geschwind, M. D., Dayalu, P., Goodnight, S. M., & Cella, D. (2016). HDQLIFE: Development and assessment of health-related quality of life in Huntington disease (HD). Quality of Life Research, 25(10), 2441–2455.CrossRefPubMed
30.
go back to reference Shoulson, I., & Fahn, S. (1979). Huntington disease clinical care and evaluation. Neurology, 29(1), 1–1.CrossRefPubMed Shoulson, I., & Fahn, S. (1979). Huntington disease clinical care and evaluation. Neurology, 29(1), 1–1.CrossRefPubMed
31.
go back to reference Marder, K., Zhao, H., Myers, R. H., Cudkowicz, M., Kayson, E., Kieburtz, K., Orme, C., Paulsen, J., Penney, J. B. Jr., Siemers, E., Shoulson, I., & Huntington Study Group. (2000). Rate of functional decline in Huntington’s disease. Neurology, 54(2), 452–458.CrossRefPubMed Marder, K., Zhao, H., Myers, R. H., Cudkowicz, M., Kayson, E., Kieburtz, K., Orme, C., Paulsen, J., Penney, J. B. Jr., Siemers, E., Shoulson, I., & Huntington Study Group. (2000). Rate of functional decline in Huntington’s disease. Neurology, 54(2), 452–458.CrossRefPubMed
32.
go back to reference Paulsen, J. S., Wang, C., Duff, K., Barker, R., Nance, M., Beglinger, L., Moser, D., Williams, J. K., Simpson, S., Langbehn, D., & van Kammen, D. P. (2010). Challenges assessing clinical endpoints in early Huntington disease. Movement Disorders, 25(15), 2595–2603.CrossRefPubMedPubMedCentral Paulsen, J. S., Wang, C., Duff, K., Barker, R., Nance, M., Beglinger, L., Moser, D., Williams, J. K., Simpson, S., Langbehn, D., & van Kammen, D. P. (2010). Challenges assessing clinical endpoints in early Huntington disease. Movement Disorders, 25(15), 2595–2603.CrossRefPubMedPubMedCentral
33.
go back to reference Hanauer, D. A., Mei, Q., Law, J., Khanna, R., & Zheng, K. (2015). Supporting information retrieval from electronic health records: A report of University of Michigan’s nine-year experience in developing and using the Electronic Medical Record Search Engine (EMERSE). Journal of Biomedical Informatics, 55, 290–300.CrossRefPubMedPubMedCentral Hanauer, D. A., Mei, Q., Law, J., Khanna, R., & Zheng, K. (2015). Supporting information retrieval from electronic health records: A report of University of Michigan’s nine-year experience in developing and using the Electronic Medical Record Search Engine (EMERSE). Journal of Biomedical Informatics, 55, 290–300.CrossRefPubMedPubMedCentral
34.
go back to reference Paulsen, J. S., Hayden, M., Stout, J. C., Langbehn, D. R., Aylward, E., Ross, C. A., Guttman, M., Nance, M., Kieburtz, K., Oakes, D., Shoulson, I., Kayson, E., Johnson, S., Penziner, E., & Investigators, P.-H. (2006). Preparing for preventive clinical trials—The Predict-HD study. Archives of Neurology, 63(6), 883–890.CrossRefPubMed Paulsen, J. S., Hayden, M., Stout, J. C., Langbehn, D. R., Aylward, E., Ross, C. A., Guttman, M., Nance, M., Kieburtz, K., Oakes, D., Shoulson, I., Kayson, E., Johnson, S., Penziner, E., & Investigators, P.-H. (2006). Preparing for preventive clinical trials—The Predict-HD study. Archives of Neurology, 63(6), 883–890.CrossRefPubMed
35.
go back to reference Amtmann, D., Kim, J., Chung, H., Bamer, A. M., Askew, R. L., Wu, S., Cook, K. F., & Johnson, K. L. (2014). Comparing CESD-10, PHQ-9, and PROMIS depression instruments in individuals with multiple sclerosis. Rehabilitation Psychology, 59(2), 220–229.CrossRefPubMedPubMedCentral Amtmann, D., Kim, J., Chung, H., Bamer, A. M., Askew, R. L., Wu, S., Cook, K. F., & Johnson, K. L. (2014). Comparing CESD-10, PHQ-9, and PROMIS depression instruments in individuals with multiple sclerosis. Rehabilitation Psychology, 59(2), 220–229.CrossRefPubMedPubMedCentral
36.
go back to reference Pilkonis, P. A., Choi, S. W., Reise, S. P., Stover, A. M., Riley, W. T., & Cella, D. (2011). Item banks for measuring emotional distress from the patient-reported outcomes measurement information system (PROMIS): Depression, anxiety, and anger. Assessment, 18(3), 263–283.CrossRefPubMedPubMedCentral Pilkonis, P. A., Choi, S. W., Reise, S. P., Stover, A. M., Riley, W. T., & Cella, D. (2011). Item banks for measuring emotional distress from the patient-reported outcomes measurement information system (PROMIS): Depression, anxiety, and anger. Assessment, 18(3), 263–283.CrossRefPubMedPubMedCentral
37.
go back to reference Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., Amtmann, D., Bode, R., Buysse, D., Choi, S., Cook, K., Devellis, R., Dewalt, D., Fries, J. F., Gershon, R., Hahn, E. A., Pilkonis, P., Revicki, D., Rose, M., Weinfurt, K., Hays, R., & Lai, J. S. & PROMIS Cooperative Group. (2010). The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. Journal of Clinical Epidemiology, 63(11), 1179–1194.CrossRefPubMedPubMedCentral Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., Amtmann, D., Bode, R., Buysse, D., Choi, S., Cook, K., Devellis, R., Dewalt, D., Fries, J. F., Gershon, R., Hahn, E. A., Pilkonis, P., Revicki, D., Rose, M., Weinfurt, K., Hays, R., & Lai, J. S. & PROMIS Cooperative Group. (2010). The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. Journal of Clinical Epidemiology, 63(11), 1179–1194.CrossRefPubMedPubMedCentral
38.
go back to reference Cella, D., Yount, S., Rothrock, N., Gershon, R., Cook, K., Reeve, B., Ader, D., Fries, J. F., Bruce, B., & Rose, M. (2007). The patient-reported outcomes measurement information system (PROMIS): Progress of an NIH Roadmap Cooperative Group during its first two years. Medical Care, 45(5 Suppl 1), S3–S11. Cella, D., Yount, S., Rothrock, N., Gershon, R., Cook, K., Reeve, B., Ader, D., Fries, J. F., Bruce, B., & Rose, M. (2007). The patient-reported outcomes measurement information system (PROMIS): Progress of an NIH Roadmap Cooperative Group during its first two years. Medical Care, 45(5 Suppl 1), S3–S11.
39.
go back to reference Callaghan, J., Stopford, C., Arran, N., Boisse, M.-F., Coleman, A., Santos, R. D., Dumas, E. M., Hart, E. P., Justo, D., & Owen, G. (2015). Reliability and factor structure of the short problem behaviors assessment for Huntington’s disease (PBA-s) in the TRACK-HD and REGISTRY studies. Journal of Neuropsychiatry and Clinical Neurosciences, 27(1), 59–64.CrossRefPubMed Callaghan, J., Stopford, C., Arran, N., Boisse, M.-F., Coleman, A., Santos, R. D., Dumas, E. M., Hart, E. P., Justo, D., & Owen, G. (2015). Reliability and factor structure of the short problem behaviors assessment for Huntington’s disease (PBA-s) in the TRACK-HD and REGISTRY studies. Journal of Neuropsychiatry and Clinical Neurosciences, 27(1), 59–64.CrossRefPubMed
40.
go back to reference Üstün, T. B., Chatterji, S., Kostanjsek, N., Rehm, J., Kennedy, C., Epping-Jordan, J., Saxena, S., Korff, M. v., & Pull, C. (2010). Developing the World Health Organization disability assessment schedule 2.0. Bulletin of the World Health Organization, 88(11), 815–823.CrossRefPubMedPubMedCentral Üstün, T. B., Chatterji, S., Kostanjsek, N., Rehm, J., Kennedy, C., Epping-Jordan, J., Saxena, S., Korff, M. v., & Pull, C. (2010). Developing the World Health Organization disability assessment schedule 2.0. Bulletin of the World Health Organization, 88(11), 815–823.CrossRefPubMedPubMedCentral
41.
go back to reference Carlozzi, N. E., Kratz, A. L., Downing, N. R., Goodnight, S., Miner, J. A., Migliore, N., & Paulsen, J. S. (2015). Validity of the 12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) in individuals with Huntington disease (HD). Quality of Life Research, 24(8), 1963–1971CrossRefPubMedPubMedCentral Carlozzi, N. E., Kratz, A. L., Downing, N. R., Goodnight, S., Miner, J. A., Migliore, N., & Paulsen, J. S. (2015). Validity of the 12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) in individuals with Huntington disease (HD). Quality of Life Research, 24(8), 1963–1971CrossRefPubMedPubMedCentral
42.
go back to reference Stroop, J. R. (1992). Studies of interference in serial verbal reactions (Reprinted from Journal Experimental-Psychology, vol. 18, pp. 643–662, 1935). Journal of Experimental Psychology: General, 121(1), 15.CrossRef Stroop, J. R. (1992). Studies of interference in serial verbal reactions (Reprinted from Journal Experimental-Psychology, vol. 18, pp. 643–662, 1935). Journal of Experimental Psychology: General, 121(1), 15.CrossRef
43.
go back to reference Beglinger, L. J., O’Rourke, J. J., Wang, C., Langbehn, D. R., Duff, K., & Paulsen, J. S. (2010). Earliest functional declines in Huntington disease. Psychiatry Research, 178(2), 414–418.CrossRefPubMedPubMedCentral Beglinger, L. J., O’Rourke, J. J., Wang, C., Langbehn, D. R., Duff, K., & Paulsen, J. S. (2010). Earliest functional declines in Huntington disease. Psychiatry Research, 178(2), 414–418.CrossRefPubMedPubMedCentral
44.
go back to reference Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). New York: Academic Press. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). New York: Academic Press.
45.
go back to reference DeVellis, R. (2017). Scale development: Theory and applications (4th edn.). Los Angeles, CA: Sage. DeVellis, R. (2017). Scale development: Theory and applications (4th edn.). Los Angeles, CA: Sage.
46.
go back to reference Cramer, D., & Howitt, D. L. (2004). The Sage dictionary of statistics. Thousand Oaks, CA: Sage.CrossRef Cramer, D., & Howitt, D. L. (2004). The Sage dictionary of statistics. Thousand Oaks, CA: Sage.CrossRef
47.
go back to reference Andresen, E. M. (2000). Criteria for assessing the tools of disability outcomes research. Archives of Physical Medicine & Rehabilitation, 81(12 Suppl 2), S15–S20.CrossRef Andresen, E. M. (2000). Criteria for assessing the tools of disability outcomes research. Archives of Physical Medicine & Rehabilitation, 81(12 Suppl 2), S15–S20.CrossRef
48.
go back to reference Campbell, D. T., & Fiske, D. W. (1959). Convergent and discriminant validation by the multitrait-multimethod matrix. Psychological Bulletin, 56(2), 81–105.CrossRefPubMed Campbell, D. T., & Fiske, D. W. (1959). Convergent and discriminant validation by the multitrait-multimethod matrix. Psychological Bulletin, 56(2), 81–105.CrossRefPubMed
49.
go back to reference Miles, J., & Shevlin, M. (2001). Applying regression and correlation: A guide for students and researchers. London: Sage Publications, Ltd. Miles, J., & Shevlin, M. (2001). Applying regression and correlation: A guide for students and researchers. London: Sage Publications, Ltd.
50.
go back to reference Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale: L. Erlbaum Associates. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale: L. Erlbaum Associates.
51.
go back to reference Youngstrom, E. A. (2014). A primer on receiver operating characteristic analysis and diagnostic efficiency statistics for pediatric psychology: We are ready to ROC. Journal of Pediatric Psychology, 39(2), 204–221.CrossRefPubMed Youngstrom, E. A. (2014). A primer on receiver operating characteristic analysis and diagnostic efficiency statistics for pediatric psychology: We are ready to ROC. Journal of Pediatric Psychology, 39(2), 204–221.CrossRefPubMed
52.
go back to reference Heaton, R. K., Miller, S. W., Taylor, J. T., & Grant, I. (2004). Revised comprehensive norms for an expanded Halstead-Reitan Battery: Demographically adjusted neuropsychological norms for African American and Caucasian adults. Lutz, FL: Psychological Assessment Resources, Inc. Heaton, R. K., Miller, S. W., Taylor, J. T., & Grant, I. (2004). Revised comprehensive norms for an expanded Halstead-Reitan Battery: Demographically adjusted neuropsychological norms for African American and Caucasian adults. Lutz, FL: Psychological Assessment Resources, Inc.
53.
go back to reference Grimes, D. A., & Schulz, K. F. (2005). Refining clinical diagnosis with likelihood ratios. The Lancet, 365(9469), 1500–1505.CrossRef Grimes, D. A., & Schulz, K. F. (2005). Refining clinical diagnosis with likelihood ratios. The Lancet, 365(9469), 1500–1505.CrossRef
54.
go back to reference Terwee, C. B., Bot, S. D., de Boer, M. R., van der Windt, D. A., Knol, D. L., Dekker, J., Bouter, L. M., & de Vet, H. C. (2007). Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology, 60(1), 34–42.CrossRefPubMed Terwee, C. B., Bot, S. D., de Boer, M. R., van der Windt, D. A., Knol, D. L., Dekker, J., Bouter, L. M., & de Vet, H. C. (2007). Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology, 60(1), 34–42.CrossRefPubMed
55.
go back to reference Duff, K., Paulsen, J. S., Beglinger, L. J., Langbehn, D. R., Wang, C., Stout, J. C., Ross, C. A., Aylward, E., Carlozzi, N. E., & Queller, S. (2010). “Frontal” behaviors before the diagnosis of Huntington’s disease and their relationship to markers of disease progression: Evidence of early lack of awareness. The Journal of Neuropsychiatry and Clinical Neurosciences, 22(2), 196–207.CrossRefPubMedPubMedCentral Duff, K., Paulsen, J. S., Beglinger, L. J., Langbehn, D. R., Wang, C., Stout, J. C., Ross, C. A., Aylward, E., Carlozzi, N. E., & Queller, S. (2010). “Frontal” behaviors before the diagnosis of Huntington’s disease and their relationship to markers of disease progression: Evidence of early lack of awareness. The Journal of Neuropsychiatry and Clinical Neurosciences, 22(2), 196–207.CrossRefPubMedPubMedCentral
56.
go back to reference Lai, J.-S., Zelko, F., Krull, K., Cella, D., Nowinski, C., Manley, P., & Goldman, S. (2014). Parent-reported cognition of children with cancer and its potential clinical usefulness. Quality of Life Research, 23(4), 1049–1058.CrossRefPubMed Lai, J.-S., Zelko, F., Krull, K., Cella, D., Nowinski, C., Manley, P., & Goldman, S. (2014). Parent-reported cognition of children with cancer and its potential clinical usefulness. Quality of Life Research, 23(4), 1049–1058.CrossRefPubMed
57.
go back to reference Choi, S., Reise, S., Pilkonis, P., Hays, R., & Cella, D. (2010). Efficiency of static and computer adaptive short forms compared to full-length measures of depressive symptoms. Quality of Life Research, 19(1), 125–136.CrossRefPubMed Choi, S., Reise, S., Pilkonis, P., Hays, R., & Cella, D. (2010). Efficiency of static and computer adaptive short forms compared to full-length measures of depressive symptoms. Quality of Life Research, 19(1), 125–136.CrossRefPubMed
58.
go back to reference Lai, J. S., Zelko, F., Butt, Z., Cella, D., Kieran, M. W., Krull, K. R., Magasi, S., & Goldman, S. (2011). Parent-perceived child cognitive function: Results from a sample drawn from the US general population. Child’s Nervous System, 27(2), 285–293.CrossRefPubMed Lai, J. S., Zelko, F., Butt, Z., Cella, D., Kieran, M. W., Krull, K. R., Magasi, S., & Goldman, S. (2011). Parent-perceived child cognitive function: Results from a sample drawn from the US general population. Child’s Nervous System, 27(2), 285–293.CrossRefPubMed
Metagegevens
Titel
Evaluating cognition in individuals with Huntington disease: Neuro-QoL cognitive functioning measures
Auteurs
Jin-Shei Lai
Siera Goodnight
Nancy R. Downing
Rebecca E. Ready
Jane S. Paulsen
Anna L. Kratz
Julie C. Stout
Michael K. McCormack
David Cella
Christopher Ross
Jenna Russell
Noelle E. Carlozzi
Publicatiedatum
08-12-2017
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 3/2018
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-017-1755-6